Literature DB >> 29106783

Gestational diabetes - is diet and insulin the only solution?

Maria Brzozowska1, Ewa Bieniek1, Konrad Szosland1, Andrzej Lewinski1.   

Abstract

Gestational diabetes (GDM) is a relatively common complication of pregnancy. Maternal hyperglycemia causes many serious side effects for mothers, fetuses and newborns. In 90% of women diagnosed with GDM, a dietary treatment results in satisfactory levels of blood glucose. The remaining 10% require insulin therapy to achieve the recommended glycemic levels. The majority of recent studies show the efficiency of metformin in gestational diabetes and prove that it is not a cause for any harmful side effects to the embryo and/or fetus. Metformin is an effective alternative to insulin in glycemic control in pregnant women. The implementation of metformin, as a routine procedure in gestational diabetes, requires further research, the results of which would unequivocally confirm its efficacy and safety for pregnant women and their offspring.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29106783

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  1 in total

1.  Comparison of Fetomaternal Outcomes in Patients With Gestational Diabetes Mellitus Treated With Insulin Versus Acarbose: Results of a Prospective, Open Label, Controlled Study.

Authors:  Suryakanta Jayasingh; Saumya Nanda; Sujata Misra; A Baliarsinha; Sidhartha Das; Anant Patil
Journal:  Cureus       Date:  2020-12-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.